Management of the circulation on the intensive care unit

Holly Speed, Gavin Hardy
{"title":"Management of the circulation on the intensive care unit","authors":"Holly Speed,&nbsp;Gavin Hardy","doi":"10.1016/j.mpsur.2024.07.002","DOIUrl":null,"url":null,"abstract":"<div><div>Mean arterial pressure (MAP) is a product of cardiac output (CO) and systemic vascular resistance. CO is calculated by multiplying stroke volume (SV) by heart rate. SV is determined by preload, cardiac contractility and afterload. These physiological parameters are targeted to manage blood pressure to maintain organ perfusion. In the hypotensive patient, assess fluid status and give intravenous (IV) crystalloid fluid resuscitation if appropriate. This optimizes the cardiac output, through an increase in end diastolic volume, based on the Frank–Starling law. If the patient's blood pressure is not fluid responsive, pharmacological intervention through inotropes, chronotropes and vasopressors may be required. A target MAP may be personalized based upon history and clinical examination. When the vasoactive intervention is escalating, cardiac monitoring may help guide further management. Mechanical circulatory support may be used in specialist centres. The hypertensive patient will be admitted to the intensive care unit (ICU) for invasive blood pressure monitoring and screening for end organ damage. Start by treating pain and anxiety. Regular oral antihypertensives may be continued if not contraindicated. IV antihypertensives in the form of beta blockers, calcium channel blockers and vasodilators may be started. Blood pressure is reduced in a controlled and rapid manner.</div></div>","PeriodicalId":74889,"journal":{"name":"Surgery (Oxford, Oxfordshire)","volume":"42 10","pages":"Pages 753-758"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery (Oxford, Oxfordshire)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0263931924001212","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Mean arterial pressure (MAP) is a product of cardiac output (CO) and systemic vascular resistance. CO is calculated by multiplying stroke volume (SV) by heart rate. SV is determined by preload, cardiac contractility and afterload. These physiological parameters are targeted to manage blood pressure to maintain organ perfusion. In the hypotensive patient, assess fluid status and give intravenous (IV) crystalloid fluid resuscitation if appropriate. This optimizes the cardiac output, through an increase in end diastolic volume, based on the Frank–Starling law. If the patient's blood pressure is not fluid responsive, pharmacological intervention through inotropes, chronotropes and vasopressors may be required. A target MAP may be personalized based upon history and clinical examination. When the vasoactive intervention is escalating, cardiac monitoring may help guide further management. Mechanical circulatory support may be used in specialist centres. The hypertensive patient will be admitted to the intensive care unit (ICU) for invasive blood pressure monitoring and screening for end organ damage. Start by treating pain and anxiety. Regular oral antihypertensives may be continued if not contraindicated. IV antihypertensives in the form of beta blockers, calcium channel blockers and vasodilators may be started. Blood pressure is reduced in a controlled and rapid manner.
重症监护室的血液循环管理
平均动脉压 (MAP) 是心输出量 (CO) 和全身血管阻力的乘积。CO 的计算方法是将每搏量 (SV) 乘以心率。SV 由前负荷、心脏收缩力和后负荷决定。这些生理参数是管理血压以维持器官灌注的目标。对于低血压患者,应评估体液状况,并酌情给予静脉晶体液复苏。根据弗兰克-斯塔林定律,这可以通过增加舒张末期容积来优化心输出量。如果患者的血压对液体没有反应,则可能需要通过肌力药、时控药和血管加压药进行药物干预。可根据病史和临床检查确定目标血压。当血管活性干预不断升级时,心脏监测可帮助指导进一步的管理。专科中心可使用机械循环支持。高血压患者将被送入重症监护室(ICU),接受有创血压监测和终末器官损伤筛查。首先治疗疼痛和焦虑。如果没有禁忌症,可继续使用常规口服降压药。可开始静脉注射β受体阻滞剂、钙通道阻滞剂和血管扩张剂等降压药。血压会以可控的方式迅速降低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.00
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信